BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 113.51 USD 0.38%
Market Cap: 27.4B USD
Have any thoughts about
BioNTech SE?
Write Note

P/OCF
Price to OCF

17.2
Current
4
Median
21.9
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
17.2
=
Market Cap
27.2B USD
/
Operating Cash Flow
1.5B EUR
All Countries
Close
Market Cap P/OCF
DE
BioNTech SE
NASDAQ:BNTX
27.2B USD 17.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 690.7
US
Abbvie Inc
NYSE:ABBV
315.2B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 19.6
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD -124
US
Epizyme Inc
F:EPE
94.1B EUR -469.3
AU
CSL Ltd
ASX:CSL
135.7B AUD 30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
36B EUR -144.4

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More